Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching.
Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching.
复制标题
通过计算机药效团开发和数据库搜索鉴定出一种新型抗利什曼病药物的活性和初步机制研究。
DOI:
10.1021/jm060156v
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Werbovetz,KarlA
中科院分区:
文献类型:
--
作者:
Delfin,DawnA;Bhattacharjee,ApurbaK;Yakovich,AdamJ;Werbovetz,KarlA
A 3D pharmacophore was generated to describe the antileishmanial activity of dinitroaniline sulfonamides by CATALYST 3D-QSAR methodology, and this pharmacophore was used to search the Maybridge database. Two compounds identified in this search, BTB 06237 and BTB 06256, were highly active with IC50values againstL.donovaniamastigotes of 0.5 ± 0.2 and 2.3 ± 0.8 μM, respectively. BTB 06237 also reduced parasite burdens inL. mexicana-infected J774 macrophages at low micromolar concentrations. Unlike the dinitroaniline sulfonamides, the active compounds did not display antimitotic effects againstLeishmania. Transmission electron microscopy showed that the single parasite mitochondrion becomes dilated following incubation with BTB 06237, and fluorescence microscopy demonstrated that this organelle fragments into intensely staining spheres when treated with a mitochondrion-specific dye. The mitochondrial membrane potential was also dissipated in BTB 06237-treated parasites. These results indicate that BTB 06237 is an intriguing antileishmanial lead compound that likely interferes with mitochondrial function.